Literature DB >> 26966404

Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancers.

T Di Valentin1, T Asmis2, J Asselah1, F Aubin1, N Aucoin1, S Berry2, J Biagi2, C M Booth2, R Burkes2, N Coburn2, B Colwell3, C Cripps2, L A Dawson2, M Dorreen3, D Frechette1, R Goel2, S Gray4, N Hammad2, D Jonker2, P Kavan2, J Maroun2, S Nanji2, D Roberge1, B Samson1, M Seal5, W Shabana1, M Simunovic2, S Snow3, M Tehfe1, M Thirlwell1, E Tsvetkova2, M Vickers6, T Vuong2, R Goodwin2.   

Abstract

The annual Eastern Canadian Colorectal Cancer Consensus Conference held in Montreal, Quebec, 17-19 October 2013, marked the 10-year anniversary of this meeting that is attended by leaders in medical, radiation, and surgical oncology. The goal of the attendees is to improve the care of patients affected by gastrointestinal malignancies. Topics discussed during the conference included pancreatic cancer, rectal cancer, and metastatic colorectal cancer.

Entities:  

Keywords:  Gastrointestinal cancer; consensus

Year:  2016        PMID： 26966404      PMCID： PMC4754060          DOI： 10.3747/co.23.2897

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


  20 in total

1.  Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement.

Authors:  Mark P Callery; Kenneth J Chang; Elliot K Fishman; Mark S Talamonti; L William Traverso; David C Linehan
Journal:  Ann Surg Oncol       Date:  2009-04-24       Impact factor: 5.344

2.  NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

Authors:  Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Anne Covey; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Sujata Rao; David P Ryan; Leonard Saltz; David Shibata; John M Skibber; Constantinos Sofocleous; James Thomas; Alan P Venook; Christopher Willett
Journal:  J Natl Compr Canc Netw       Date:  2009-09       Impact factor: 11.908

Review 3.  Laparoscopy in the staging of pancreatic cancer.

Authors:  P W Pisters; J E Lee; J N Vauthey; C Charnsangavej; D B Evans
Journal:  Br J Surg       Date:  2001-03       Impact factor: 6.939

4.  Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease.

Authors:  M Vickers; B Samson; B Colwell; C Cripps; D Jalink; S El-Sayed; E Chen; G Porter; R Goel; J Villeneuve; S Sundaresan; J Asselah; J Biagi; D Jonker; L Dawson; R Letourneau; M Rother; J Maroun; M Thirlwell; M Hussein; M Tehfe; N Perrin; N Michaud; N Hammad; P Champion; R Rajan; R Burkes; S Barrette; S Welch; N Yarom; T Asmis
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

5.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

6.  Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials.

Authors:  Christian Weiss; Dirk Arnold; Kathrin Dellas; Torsten Liersch; Matthias Hipp; Rainer Fietkau; Rolf Sauer; Axel Hinke; Claus Rödel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-03       Impact factor: 7.038

7.  High dose rate endorectal brachytherapy as a neoadjuvant treatment for patients with resectable rectal cancer.

Authors:  T Vuong; S Devic; E Podgorsak
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-08-22       Impact factor: 4.126

8.  A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Authors:  Saila P Kauhanen; Gaber Komar; Marko P Seppänen; Kirsti I Dean; Heikki R Minn; Sami A Kajander; Irina Rinta-Kiikka; Kalle Alanen; Ronald J Borra; Pauli A Puolakkainen; Pirjo Nuutila; Jari T Ovaska
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

9.  Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Authors:  Axel Grothey; Eric Van Cutsem; Alberto Sobrero; Salvatore Siena; Alfredo Falcone; Marc Ychou; Yves Humblet; Olivier Bouché; Laurent Mineur; Carlo Barone; Antoine Adenis; Josep Tabernero; Takayuki Yoshino; Heinz-Josef Lenz; Richard M Goldberg; Daniel J Sargent; Frank Cihon; Lisa Cupit; Andrea Wagner; Dirk Laurent
Journal:  Lancet       Date:  2012-11-22       Impact factor: 79.321

Review 10.  Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT.

Authors:  S L Smith; P S Rajan
Journal:  Clin Radiol       Date:  2004-01       Impact factor: 2.350
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.